Clinical Trial Update: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating LUM-201 for children with growth hormone deficiency has completed, providing the Phase 2 readout for the investigational treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• LUM-201

Snippet

Sponsor: Lumos Pharma | Conditions: Growth Hormone Deficiency | Phase 2 | Status: COMPLETED